Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023380 (
lethargy
)
5,697
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Visual evoked potentials were utilized to examine the neuronal transmission changes provoked by galactosamine-induced hepatic encephalopathy and by administration in normal animals of toxins presumably involved in the pathogenesis of hepatic encepalopathy. Separate acute administrations of ammonia, dimethyldisulfide, and octanoic acid induced
lethargy
, convulsions in the case of the first two, and coma with visual-evoked potential patterns that never resembled the evoked potentials recorded in
hepatic coma
. By contrast, single and repeated administrations of the three above-mentioned toxins together at lower doses induced
lethargy
and coma with visual-evoked potential patterns similar to those observed in galactosamine-induced
hepatic coma
. These observations, together with previously published data, are consistent with the concept that the synergistic interaction of these toxins plays a significant role in the pathogenesis of hepatic encephalopathy.
...
PMID:Visual evoked potentials in encephalopathy induced by galactosamine, ammonia, dimethyldisulfide, and octanoic acid. 711 66
Ornithine transcarbamylase deficiency is the most common inherited urea cycle disorder. Its clinical manifestations as
lethargy
, vomites, coma and cerebral edema are the effect of the higher concentration of the ammonia in plasma. Hyperammonemia, caused by mutation in ornithine transcarbamylase gene, is often considered as a reason of coma by pediatricians but skipped by internist, although it is the third reason of
hepatic coma
in adults. This article is the recapitulation of published studies and their implication on everyday clinical practice.
...
PMID:[Hyperammonemia type II as an example of urea cycle disorder]. 1720 50